Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma With Bronchiolo-alveolar Feature”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableLooking for participantsNCT07219251
What this trial is testing

Engagement of Veterans With Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)Lung AdenocarcinomaLung Cancer, Non-Small Cell+3 more
Palo Alto Veterans Institute for Research 194
Testing effectiveness (Phase 2)Study completedNCT00118144
What this trial is testing

Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer

Who this might be right for
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerNon-small Cell Lung Cancer+3 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00103207
What this trial is testing

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 72
Testing effectiveness (Phase 2)Ended earlyNCT00117351
What this trial is testing

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma, Bronchiolo-Alveolar
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00198380
What this trial is testing

Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

Who this might be right for
Pneumonic-type Adenocarcinoma (P-ADC)Lung Adenocarcinoma With Bronchiolo-alveolar Feature
Intergroupe Francophone de Cancerologie Thoracique 90
Testing effectiveness (Phase 2)Study completedNCT00436332
What this trial is testing

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 84